https://doi.org/10.1016/j.fgb.2017.10.007
X
Xiaoyang Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
716
Citations
14
h-index
19
i10-index
Xiaoyang Yu is an academic researcher from Institute of Chemical Technology. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Hepatitis B Virus Studies & Hepatitis C virus research. The author has an h-index of 14, co-authored 54 publications.
ORCID: 0000-0003-1525-3169Papers by this author
worksDifferential roles of three FgPLD genes in regulating development and pathogenicity in Fusarium graminearum
2017 · Fungal Genetics and Biology · 52 citations
Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription
2023 · Antiviral Research · 24 citations
https://doi.org/10.1016/j.antiviral.2023.105552
NEDD4 family ubiquitin ligase AIP4 interacts with Alix to enable HBV naked capsid egress in an Alix ubiquitination-independent manner
2024 · PLoS Pathogens · 9 citations
https://doi.org/10.1371/journal.ppat.1012485
Clinico-pathological features of diabetic and non-diabetic renal diseases in type 2 diabetic patients: a retrospective study from a 10-year experience in a single center
2023 · International Urology and Nephrology · 7 citations
https://doi.org/10.1007/s11255-023-03478-4
Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis
2024 · Renal Failure · 6 citations
https://doi.org/10.1080/0886022x.2024.2365408
The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing
2024 · Journal of Virology · 5 citations
https://doi.org/10.1128/jvi.01187-24
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat